Treatment with calcimimetics in kidney transplantation.
Morales
Enrique
E
Nephrology Department, Hospital 12 de Octubre, Madrid, Spain.
Gutierrez
Eduardo
E
Andres
Amado
A
D001847:Bone Diseases / Q000453:epidemiology / Q000209:etiology; D001851:Bone Diseases, Metabolic / Q000453:epidemiology / Q000209:etiology; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000453:epidemiology / Q000209:etiology; D000069449:Cinacalcet; D006085:Graft Survival; D006801:Humans; D006934:Hypercalcemia / Q000453:epidemiology / Q000209:etiology; D006961:Hyperparathyroidism / Q000453:epidemiology / Q000209:etiology; D017674:Hypophosphatemia / Q000453:epidemiology / Q000209:etiology; D016030:Kidney Transplantation / Q000009:adverse effects / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D008903:Minerals / Q000378:metabolism*; D009281:Naphthalenes / Q000627:therapeutic use; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology / Q000209:etiology; D016019:Survival Analysis; D014808:Vitamin D Deficiency / Q000453:epidemiology / Q000209:etiology
D008903:Minerals; D009281:Naphthalenes; D000069449:Cinacalcet